AUTHOR=Zhang Jinjia , Gao Yiyang , Li Yongze , Teng Di , Xue Yuanming , Yan Li , Yang Jing , Yang Lihui , Yao Yongli , Ba Jianming , Chen Bing , Du Jianling , He Lanjie , Lai Xiaoyang , Teng Xiaochun , Shi Xiaoguang , Li Yanbo , Chi Haiyi , Liao Eryuan , Liu Chao , Liu Libin , Qin Guijun , Qin Yingfen , Quan Huibiao , Shi Bingyin , Sun Hui , Tang Xulei , Tong Nanwei , Wang Guixia , Zhang Jin-an , Wang Youmin , Ye Zhen , Zhang Qiao , Zhang Lihui , Zhu Jun , Zhu Mei , Teng Weiping , Shan Zhongyan , Li Jing TITLE=The Presence of Serum TgAb Suggests Lower Risks for Glucose and Lipid Metabolic Disorders in Euthyroid General Population From a National Survey JOURNAL=Frontiers in Endocrinology VOLUME=11 YEAR=2020 URL=https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2020.00139 DOI=10.3389/fendo.2020.00139 ISSN=1664-2392 ABSTRACT=

Purpose: The expressions of antibodies against thyroid peroxidase (TPOAb) and thyroglobulin (TgAb) are very common in the sera of patients with autoimmune thyroid diseases (AITD). The relationship between thyroid autoantibodies and the occurrence of glucose and lipid metabolic disorders remains unclear. This study was performed to investigate the correlation between the presence of serum TPOAb/TgAb and those metabolic disorders in euthyroid general population.

Methods: The data of this study were derived from the Thyroid Disease, Iodine status, and Diabetes National epidemiological (TIDE) survey from all 31 provinces of mainland China. A total of 17,964 euthyroid subjects including 5,802 males (4,000 with TPOAbTgAb and 1,802 with TPOAb+/TgAb+) and 12,162 females (8,000 with TPOAbTgAb and 4,162 with TPOAb+/TgAb+) were enrolled in this study. The blood glucose and lipid levels were compared between individuals with TPOAbTgAb and those with TPOAb+TgAb, TPOAbTgAb+, TPOAb+TgAb+.

Results: Both fasting blood glucose (FBG) concentration and the proportion of individuals with impaired FBG (IFG) showed the decreased trends in TPOAbTgAb+ males as compared with TPOAbTgAb men. There were significantly lower FBG and higher HDL-C levels as well as tendencies toward decreased incidences of IGT and hypertriglyceridemia in TPOAbTgAb+ females when compared with TPOAbTgAb women. Binary logistic regression analysis further showed that serum TgAb single positivity in males was an independent protective factor for IFG with an OR of 0.691 (95% CI, 0.503–0.949). For females, serum TgAb single positivity was an independent protective factor for hypertriglyceridemia with an OR of 0.859 (95% CI, 0.748–0.987). Trend test showed that with the increase of serum TgAb level, there were significant decreases in the prevalence of IFG among the men with TSH ≤ 2.5 mIU/L and that of hypertriglyceridemia in the women, especially among non-obese females.

Conclusion: Serum TgAb single positivity may imply a reduced risk of IFG in euthyroid men and that of hypertriglyceridemia in euthyroid women. The mechanisms for the independent protective roles of TgAb await further investigation.